White Paper: How SEND Supports Ethical Innovation with the VICT3R Consortium

This white paper explores how SEND-aligned data management is enabling the development of virtual control groups (VCGs), a transformative approach with the potential to significantly reduce animal use in preclinical drug safety studies.

Advancing ethical innovation in toxicology requires more than new ideas, it demands robust data, harmonized standards, and regulatory-ready infrastructure.

This white paper introduces the scientific and ethical foundations of VCGs and explains how the VICT3R consortium is working to validate and promote wider adoption. You’ll learn how historical control data can be leveraged to replace or reduce concurrent animal control groups, the technical and regulatory challenges that must be overcome, and why data standardization is essential for success.

As a contributing partner to VICT3R, Instem brings deep expertise in preclinical data management, regulatory compliance, and SEND implementation. This paper outlines Instem’s role in building SEND-aligned data structures, governance frameworks, and systems of record that improve data quality, interoperability, and readiness for regulatory scrutiny.

Complete the form to download this resource and gain insight into how SEND, virtual control groups, and collaborative data standards are shaping the future of ethical and efficient toxicology research.

Get This Resource

Share This Resource